{"id":229403,"date":"2026-09-03T12:54:19","date_gmt":"2026-09-03T07:24:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=229403"},"modified":"2026-09-03T12:54:19","modified_gmt":"2026-09-03T07:24:19","slug":"why-torrent-pharmaceuticals-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/","title":{"rendered":"Torrent Pharmaceuticals (TORNTPHARM) Share Price Falls 2.19% to Rs 4,895; Valuation and Peer Analysis in Focus"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\">Torrent Pharmaceuticals (TORNTPHARM)<\/a>share price fell to Rs 4,895 today, down 2.19% from the previous close. Market cap was Rs 1,88,622.52 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Torrent Pharmaceuticals Share Price fell to Rs 4,895 on 03 September 2026 at 12:49:14 PM IST, down 2.19% for the day. The stock was lower by Rs 109.4 from the previous close of Rs 5,004.4, while the company\u2019s market capitalisation stood at Rs 1,88,622.52 crore.<\/p>\n<p>The supplied data confirms the decline, but it does not identify a company-specific trigger. That means today\u2019s move is best read through price action, valuation and industry positioning rather than any unverified reason. For market participants tracking the stock, the session shows a weak intraday structure: the open was also the day\u2019s high, and the current price matched the day\u2019s low.<\/p>\n<p>This makes the stock notable not only because it is down on the day, but also because it belongs to the large-cap pharmaceutical space and trades at premium valuation multiples. At the same time, profitability ratios remain stronger than many industry benchmarks, so the current setup combines rich pricing with healthy historical returns.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Torrent_Pharmaceuticals_TORNTPHARM_Share_Price_Today_Price_Action_Analysis\" title=\"Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis\">Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Torrent_Pharmaceuticals_TORNTPHARM_Fundamental_Analysis\" title=\"Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis\">Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Torrent_Pharmaceuticals\" title=\"Why Investors Are Watching Torrent Pharmaceuticals\">Why Investors Are Watching Torrent Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#About_Torrent_Pharmaceuticals\" title=\"About Torrent Pharmaceuticals\">About Torrent Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Track_Torrent_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Torrent Pharmaceuticals Share Price on Univest\">Track Torrent Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Why_is_Torrent_Pharmaceuticals_Share_Price_falling_today\" title=\"Why is Torrent Pharmaceuticals Share Price falling today?\">Why is Torrent Pharmaceuticals Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#What_is_Torrent_Pharmaceuticals_Share_Price_Today\" title=\"What is Torrent Pharmaceuticals Share Price Today?\">What is Torrent Pharmaceuticals Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#How_did_the_stock_perform_intraday_today\" title=\"How did the stock perform intraday today?\">How did the stock perform intraday today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#What_does_the_PE_ratio_indicate\" title=\"What does the P\/E ratio indicate?\">What does the P\/E ratio indicate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#How_does_the_PB_ratio_compare_with_the_industry\" title=\"How does the P\/B ratio compare with the industry?\">How does the P\/B ratio compare with the industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#Are_the_profitability_ratios_strong\" title=\"Are the profitability ratios strong?\">Are the profitability ratios strong?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#How_does_Torrent_compare_with_major_pharma_peers\" title=\"How does Torrent compare with major pharma peers?\">How does Torrent compare with major pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-torrent-pharmaceuticals-share-price-fall-today-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_TORNTPHARM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,895<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,004.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 109.40 (-2.19%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,048.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,048.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,895<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,88,622.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Torrent Pharmaceuticals Share Price Today reflects a clear slide through the session. The stock opened at Rs 5,048.55, which was also the intraday high, and then moved down to Rs 4,895, the day\u2019s low and current price at the supplied snapshot.<\/p>\n<p>Versus the previous close of Rs 5,004.4, the stock was down Rs 109.4, or 2.19%. That indicates the early opening strength did not hold. Turnover stood at Rs 1.08 crore, confirming active trading value during the move.<\/p>\n<p>The technical snapshot adds context. The stock is below the 50-day moving average of Rs 4,945.51, but still above the 200-day moving average of Rs 4,447.92. RSI was 51.8, which places the momentum reading near the middle rather than at an extreme. Taken together, the available numbers point to short-term weakness inside a longer-term level that still sits above the 200-day average.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_TORNTPHARM_Fundamental_Analysis\"><\/span><strong>Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,88,622.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">87.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 57.34<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 235.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.76%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Torrent Pharmaceuticals fundamental analysis shows a mix that often draws attention during down sessions: strong return ratios alongside expensive valuation multiples. In other words, the stock is not merely reacting to a one-day fall; it is also being judged against the price investors are paying for earnings and net worth.<\/p>\n<p>At a market cap of Rs 1,88,622.52 crore, the company sits firmly in the large-cap bracket. The stock trades at a P\/E ratio of 87.28 and a P\/B ratio of 21.21, both elevated on an absolute basis. Profitability is stronger, with ROE at 26.76% and ROCE at 19.27%.<\/p>\n<p>EPS stands at Rs 57.34 and book value per share at Rs 235.97. Dividend yield is 0.76%. These figures do not explain today\u2019s fall on their own, but they do show why valuation remains central when the stock comes under pressure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">87.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.6x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.49x to 648.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.15%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,88,622.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 727.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,141.34 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The same-industry benchmark covers 201 companies in Pharmaceuticals &amp; Drugs. Against that set, Torrent is clearly priced above typical valuation levels. Its P\/E of 87.28 is well above the median of 31.97 and the average of 48.6. The stock\u2019s P\/B of 21.21 is also far above the median of 2.87 and average of 4.35.<\/p>\n<p>Profitability, however, compares more favourably. ROE of 26.76% is ahead of the benchmark median of 11.79% and average of 11.15%. ROCE of 19.27% is also above the median of 13.63% and average of 13.69%.<\/p>\n<p>Scale is another differentiator. The company\u2019s market capitalisation of Rs 1,88,622.52 crore is far above the industry median of Rs 727.27 crore and average of Rs 14,141.34 crore, though below the benchmark maximum of Rs 4,63,179.62 crore. The sector picture therefore suggests a premium valuation attached to a large business with above-benchmark returns.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,63,179.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,43,301.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,16,114.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,00,498.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">92.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The peer set shows Torrent as a large pharma name with one of the richer valuations in the group. Sun Pharmaceutical Industries has the biggest market cap at Rs 4,63,179.62 crore, but much lower P\/E and P\/B ratios of 38.34 and 5.36. Divi&#8217;s Laboratories is closer on valuation at 83.79 P\/E and 13.88 P\/B, though still below Torrent on both measures.<\/p>\n<p>Zydus Lifesciences and Cipla trade at notably lower multiples, with P\/E ratios of 25.44 and 33.87 respectively. Their P\/B ratios of 4.26 and 3.25 are also much lower. Laurus Labs is one of the few peers with a higher P\/E at 92.06, but its market cap is smaller at Rs 1,00,498.07 crore.<\/p>\n<p>On profitability, Torrent\u2019s ROE of 26.76% is above Sun Pharma, Divi\u2019s, Zydus, Cipla and Laurus Labs. Its ROCE of 19.27% is close to Sun Pharma\u2019s 19.11%, above Cipla\u2019s 16 and Laurus Labs\u2019 18.2, but below Divi\u2019s 21.51 and Zydus 21.39. That profile supports why the stock commands a premium, even if the valuation is demanding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Torrent_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Torrent Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock fell 2.19% to Rs 4,895, down Rs 109.4 from the previous close of Rs 5,004.4.<\/li>\n<li>The open at Rs 5,048.55 was also the day\u2019s high, while Rs 4,895 marked the low and current price.<\/li>\n<li>P\/E of 87.28 and P\/B of 21.21 are well above industry median levels.<\/li>\n<li>ROE of 26.76% and ROCE of 19.27% remain above broader same-industry averages.<\/li>\n<li>Market capitalisation of Rs 1,88,622.52 crore keeps the company among the larger listed pharma names.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Torrent_Pharmaceuticals\"><\/span><strong>About Torrent Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Torrent Pharmaceuticals is listed in the Healthcare sector under Pharmaceuticals &amp; Drugs. Based on the supplied market and peer data, it is one of the larger companies in the industry set. In the peer universe provided here, it sits below Sun Pharmaceutical Industries and Divi&#8217;s Laboratories on market cap, but above Zydus Lifesciences, Cipla and Laurus Labs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Torrent_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Torrent Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\">Torrent Pharmaceuticals (TORNTPHARM) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>On Univest, readers can track Torrent Pharmaceuticals Share Price through live price updates, valuation ratios, profitability metrics, sector benchmarks and peer comparisons. That gives context for a one-day move without forcing a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Torrent_Pharmaceuticals_Share_Price_falling_today\"><\/span><strong>Why is Torrent Pharmaceuticals Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Torrent Pharmaceuticals Share Price was down 2.19% at Rs 4,895, a decline of Rs 109.4 from the previous close of Rs 5,004.4. The supplied data confirms the fall, but it does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Torrent_Pharmaceuticals_Share_Price_Today\"><\/span><strong>What is Torrent Pharmaceuticals Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;It stood at Rs 4,895 at the supplied snapshot time of 12:49:14 PM IST on 03 September 2026, versus the previous close of Rs 5,004.4. The stock moved 2.19% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_the_stock_perform_intraday_today\"><\/span><strong>How did the stock perform intraday today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock opened at Rs 5,048.55, which was also the day\u2019s high, and then declined to Rs 4,895, the day\u2019s low and current price. That indicates weakness through the session rather than a recovery from lower levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_PE_ratio_indicate\"><\/span><strong>What does the P\/E ratio indicate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock trades at a P\/E of 87.28, compared with the same-industry median of 31.97 and average of 48.6. That places it at a premium valuation versus much of the Pharmaceuticals &amp; Drugs benchmark universe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_PB_ratio_compare_with_the_industry\"><\/span><strong>How does the P\/B ratio compare with the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The company\u2019s P\/B ratio is 21.21, well above the industry median of 2.87 and average of 4.35. This suggests the market is assigning a substantial premium relative to book value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_the_profitability_ratios_strong\"><\/span><strong>Are the profitability ratios strong?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;ROE stands at 26.76% and ROCE at 19.27%, both above the same-industry averages of 11.15% and 13.69% respectively. The relevant peer median ROE is 11.79%. The relevant peer median ROCE is 13.63%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Torrent_compare_with_major_pharma_peers\"><\/span><strong>How does Torrent compare with major pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Its P\/E of 87.28 is higher than Sun Pharma, Zydus and Cipla, slightly above Divi&#39;s Laboratories, and below Laurus Labs. Its ROE of 26.76% is stronger than the supplied peers, while ROCE is mixed across the comparison set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors may watch whether the stock holds around Rs 4,895 after slipping below the 50-day moving average of Rs 4,945.51, while still remaining above the 200-day moving average of Rs 4,447.92.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Torrent Pharmaceuticals Share Price falls to Rs 4,895. marking a 2.19% fall today. Market cap stands at Rs 1,88,622.52 crore.<\/p>\n","protected":false},"author":29,"featured_media":229402,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-229403","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["229402"],"rank_math_title":["Torrent Pharmaceuticals Share Price Falls 2.19% Analysis"],"rank_math_description":["Torrent Pharmaceuticals Share Price fell 2.19% to Rs 4,895. Read price action, valuation, sector benchmark and peer analysis for the pharma stock."],"rank_math_focus_keyword":["Torrent Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Torrent_Pharmaceuticals_TORNTPHARM_Share_Price_Falls_219_to_Rs_4895_Valuation_and_Peer_Analysis_in_Focus_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/229403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=229403"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/229403\/revisions"}],"predecessor-version":[{"id":229404,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/229403\/revisions\/229404"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/229402"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=229403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=229403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=229403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}